ArticleBreast cancer research and treatment2023

Baseline interleukin-6 is a prognostic factor for patients with metastatic breast cancer treated with eribulin.

Ayako Bun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.